Xtl biopharmaceuticals ltd

Major-Pharmaceuticals

XTLB


5 Badner Street
Ramat Gan , 4365603

Executive/
Director

Price

  • Last Close
  • $ 2.17
    $ +0.4 22.6 %
    Jan 3, 2025
  • 52-Week High/Low
  • $3.33 - $0.78
  • YTD
  • 9%

  • Trading Volume
  • 500
  • Market Cap Full
  • $ 1.2B
  • Shares Outstanding
  • 544.9M
    Dec 31, 2022
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -26.8% -17% -24.5% 36.4% -5% 9.9% -14.4% 15.7% 182.8% 9.1%
Q2 12.4% 20.2% 3.2% -13.6% 4% 19.8% -35.9% -28.5% -26.9% -
Q3 -18.1% -24.1% 18.2% -25.8% 8% 10.3% -27% 5.2% -5.4% -
Q4 -33.3% -8.4% -23.1% -8.3% 59.5% -37.1% 3.6% 4% 16.4% -
J F M A M J J A S O N D
2025 9.1% - - - - - - - - - - -
2024 -17% 3.5% 229% -20% 17.9% -15.5% 25.6% -5.4% - - - 5.3%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    -29%-55%-28%-24%-24%130%-9%-58%-14%101%9%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - 0.2 0.8 - 0.1 0.09 -0.17
Q2 0.04 - - - - -0.22 -0.05 -0.07
Q3 0.02 0.08 - - - - - -0.04
Q4 0.12 - - - - - -0.14 -
A 0.2 0.1 0.2 0.8 0 -0.1 -0.1 -0.28

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2019 2020 2021 2022
Mar 514.2 - - -
Jun - - - -
Sep - - - -
Dec 514.2 514.2 544.9 544.9

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - 1 - - 0.3
Equity multiplier - - - - -